[go: up one dir, main page]

DE69706146D1 - Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen - Google Patents

Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen

Info

Publication number
DE69706146D1
DE69706146D1 DE69706146T DE69706146T DE69706146D1 DE 69706146 D1 DE69706146 D1 DE 69706146D1 DE 69706146 T DE69706146 T DE 69706146T DE 69706146 T DE69706146 T DE 69706146T DE 69706146 D1 DE69706146 D1 DE 69706146D1
Authority
DE
Germany
Prior art keywords
taxoids
production
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69706146T
Other languages
English (en)
Other versions
DE69706146T2 (de
Inventor
Herve Bouchard
Jean-Dominique Bourzat
Alain Commercon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69706146D1 publication Critical patent/DE69706146D1/de
Publication of DE69706146T2 publication Critical patent/DE69706146T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69706146T 1996-03-06 1997-03-05 Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen Expired - Fee Related DE69706146T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602804A FR2745814B1 (fr) 1996-03-06 1996-03-06 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1997/000386 WO1997032869A1 (fr) 1996-03-06 1997-03-05 Taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE69706146D1 true DE69706146D1 (de) 2001-09-20
DE69706146T2 DE69706146T2 (de) 2002-05-02

Family

ID=9489910

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69706146T Expired - Fee Related DE69706146T2 (de) 1996-03-06 1997-03-05 Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen

Country Status (34)

Country Link
US (1) US6160135A (de)
EP (1) EP0885208B1 (de)
JP (1) JP2000506158A (de)
KR (1) KR19990087398A (de)
CN (1) CN1210525A (de)
AP (1) AP1023A (de)
AT (1) ATE204266T1 (de)
AU (1) AU715228B2 (de)
BG (1) BG63693B1 (de)
BR (1) BR9707887A (de)
CA (1) CA2248195A1 (de)
CZ (1) CZ283498A3 (de)
DE (1) DE69706146T2 (de)
DK (1) DK0885208T3 (de)
EA (1) EA001516B1 (de)
EE (1) EE03611B1 (de)
ES (1) ES2161446T3 (de)
FR (1) FR2745814B1 (de)
GE (1) GEP20012517B (de)
GR (1) GR3036410T3 (de)
HU (1) HUP9902425A3 (de)
IL (1) IL125998A (de)
IS (1) IS4809A (de)
NO (1) NO983472D0 (de)
NZ (1) NZ331040A (de)
OA (1) OA10855A (de)
PL (1) PL328691A1 (de)
PT (1) PT885208E (de)
SK (1) SK121598A3 (de)
TR (1) TR199801732T2 (de)
TW (1) TW474928B (de)
WO (1) WO1997032869A1 (de)
YU (1) YU38398A (de)
ZA (1) ZA971746B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
CA2314071A1 (en) * 1997-12-19 1999-07-01 Kabushiki Kaisha Yakult Honsha Taxane derivatives
EP1020188A1 (de) * 1999-01-13 2000-07-19 Aventis Pharma S.A. Neue Verwendung von Taxoid-Derivaten
CO5280224A1 (es) * 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
GEP20043239B (en) 2000-02-02 2004-05-25 Florida State Univ Research Foundation Us C10 Carbonate Substituted Taxanes as Antitumor Agents
CZ2003837A3 (cs) 2000-09-22 2004-12-15 Bristol-Myers Squibb Company Způsob pro snížení toxicity při kombinovaných chemoterapiích
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
SV2006002036A (es) 2004-03-05 2006-03-16 Univ Florida State Res Found Taxanos con sustituyente lactiloxilo en el c7
AU2008288651A1 (en) * 2007-08-22 2009-02-26 6570763 Canada Inc. Process for converting 9-dihydro-13-acetylbaccatin III into docetaxel or paclitaxel
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
SG10201810928SA (en) 2009-10-29 2019-01-30 Aventis Pharma Sa Novel antitumoral use of cabazitaxel
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
EP0555485A4 (en) * 1991-07-17 1993-11-03 Nippon Steel Corporation Antitumor compound nsc-lsc1 and production thereof
CA2100808A1 (en) * 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
PT689436E (pt) * 1993-03-22 2004-04-30 Univ Florida State Taxanos que nao possuem um grupo oxo em c-9 e composicoes farmaceuticas que os contem
FR2711369B1 (fr) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
CN1073105C (zh) * 1994-07-26 2001-10-17 因迪纳有限公司 具有抗肿瘤活性的半合成紫杉烷
US6201140B1 (en) * 1994-07-28 2001-03-13 Bristol-Myers Squibb Company 7-0-ethers of taxane derivatives

Also Published As

Publication number Publication date
AU2030297A (en) 1997-09-22
PT885208E (pt) 2001-11-30
WO1997032869A1 (fr) 1997-09-12
NZ331040A (en) 2000-02-28
IL125998A (en) 2002-02-10
EE9800264A (et) 1999-02-15
CZ283498A3 (cs) 1999-01-13
PL328691A1 (en) 1999-02-15
AU715228B2 (en) 2000-01-20
ES2161446T3 (es) 2001-12-01
BG63693B1 (bg) 2002-09-30
CN1210525A (zh) 1999-03-10
EE03611B1 (et) 2002-02-15
HUP9902425A3 (en) 2001-08-28
FR2745814A1 (fr) 1997-09-12
BR9707887A (pt) 1999-09-21
BG102753A (en) 1999-09-30
EA001516B1 (ru) 2001-04-23
JP2000506158A (ja) 2000-05-23
TW474928B (en) 2002-02-01
AP1023A (en) 2001-11-16
HUP9902425A2 (hu) 2001-04-28
AP9801335A0 (en) 1998-09-30
EA199800795A1 (ru) 1999-02-25
GR3036410T3 (en) 2001-11-30
NO983472L (no) 1998-07-28
KR19990087398A (ko) 1999-12-27
EP0885208B1 (de) 2001-08-16
OA10855A (fr) 2003-02-05
ATE204266T1 (de) 2001-09-15
EP0885208A1 (de) 1998-12-23
DK0885208T3 (da) 2001-10-15
FR2745814B1 (fr) 1998-04-03
GEP20012517B (en) 2001-08-27
ZA971746B (en) 1997-09-16
SK121598A3 (en) 1999-01-11
IL125998A0 (en) 1999-04-11
DE69706146T2 (de) 2002-05-02
IS4809A (is) 1998-07-24
US6160135A (en) 2000-12-12
TR199801732T2 (xx) 1998-12-21
CA2248195A1 (fr) 1997-09-12
YU38398A (sh) 1999-07-28
NO983472D0 (no) 1998-07-28

Similar Documents

Publication Publication Date Title
ATE188471T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DE69928260D1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
DE69630145D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DK0747050T4 (da) Farmaceutiske sammensætninger, der indeholder irbesartan
DE60138872D1 (de) Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATA188592A (de) Alkyl-bisacylphosphinoxide, diese enthaltende zusammensetzungen und ihre verwendung
ATE164843T1 (de) Naphthalinderivate, ihre herstellungsverfahren und zwischenprodukte dafür, und diese enthaltende pharmazeutische zusammensetzungen
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
DE69715009D1 (de) Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten
DE69706146D1 (de) Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69608680D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
FR2712288B1 (fr) Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
DE69610085D1 (de) Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE252096T1 (de) Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
EP0672052A1 (de) Tachyquinin antagonisten, ihre herstellung und ihre verwendung in pharmazeutischen formulierungen.
TR199501082A2 (tr) Farmasötik formülasyonlar.
FR2721023B1 (fr) Nouveaux Taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
DE68914700D1 (de) Polymere Zusammensetzungen und ihre Herstellung.
DE69614568D1 (de) Neue taxoide, herstellung und pharmazeutische zusammensetzungen diese enthaltend
DE69311463D1 (de) Pfropfpolymerteilchen, herstellung davon, und diese enthaltende zusammensetzung
DE69509621D1 (de) Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung
FR2711370B1 (fr) Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
ATE157360T1 (de) Thienocyclopentanonoximether, ihre herstellung und diese enthaltende arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee